Empresa ESSA Pharma Inc Toronto S.E.
Acciones
EPI
CA29668H1047
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 24/06/15 |
David Wood
DFI | Director of Finance/CFO | 66 | 01/10/13 |
Peter Virsik
COO | Chief Operating Officer | - | 01/08/16 |
Chief Tech/Sci/R&D Officer | 63 | 15/07/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 05/03/15 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 31/07/19 |
Richard Glickman
CHM | Chairman | 65 | 01/10/10 |
Director/Board Member | 55 | 31/07/19 | |
Scott Requadt
BRD | Director/Board Member | 56 | 14/01/16 |
David Parkinson
CEO | Chief Executive Officer | 73 | 24/06/15 |
Philip Kantoff
BRD | Director/Board Member | 69 | 13/09/22 |
Ann Thorell
BRD | Director/Board Member | 56 | 31/07/19 |
Gary Sollis
BRD | Director/Board Member | 69 | 26/04/12 |
Lauren Merendino
BRD | Director/Board Member | 49 | 06/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 44 238 147 | 43 230 993 ( 97,72 %) | 0 | 97,72 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+22,81 % | 44,96 mil M | |
+0,76 % | 42,65 mil M | |
+46,00 % | 41,85 mil M | |
-5,31 % | 29,04 mil M | |
+10,93 % | 26,08 mil M | |
-21,22 % | 19,03 mil M | |
+6,32 % | 12,75 mil M | |
+28,78 % | 12,06 mil M | |
-3,41 % | 11,75 mil M |